Loading clinical trials...
Loading clinical trials...
An Observational Study of Patients With Philadelphia Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
A retrospective chart review study of Philadelphia chromosome-negative R/R ALL patients in the US.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Research Site
Tucson, Arizona, United States
Research Site
Duarte, California, United States
Research Site
Los Angeles, California, United States
Research Site
Chicago, Illinois, United States
Research Site
Ames, Iowa, United States
Research Site
New Orleans, Louisiana, United States
Research Site
Baltimore, Maryland, United States
Research Site
Baltimore, Maryland, United States
Research Site
Detroit, Michigan, United States
Research Site
Hackensack, New Jersey, United States
Start Date
June 30, 2016
Primary Completion Date
March 31, 2020
Completion Date
March 31, 2020
Last Updated
April 27, 2020
212
ACTUAL participants
Other
OTHER
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions